Genus PLC (LON:GNS) Rating Reaffirmed
In a note revealed to investors and clients this morning, Liberum Capital has reaffirmed their “Hold” rating on Genus PLC (LON:GNS) shares. The Estimated Target Price would possibly suggest a possible upside of 3.13% from firm’s stock close price.
From a total of 5 analysts covering Genus PLC (LON:GNS) stock, 2 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 40% of the ratings are positive. The highest target price is GBX 1550 while the lowest target price is GBX 1426. The mean of all analyst targets is GBX 1488.6 with a 2.10% above today’s (GBX 1458) stock price. Genus PLC was the topic of 24 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Liberum Capital maintained shares on December 14 with “Hold” rating. N+1 Singer maintained GNS stock in a recent report from November 19 with “Hold” rating. Finally, Numis Securities maintained the stock with “Hold” rating in a report issued on a September 8.
Approximately 1,485 shares of stock traded hands. Genus plc (LON:GNS) has declined 1.75% since May 15, 2015 and is downtrending. It has outperformed by 2.66% the S&P500.
Genus plc is a United Kingdom-based animal genetics company. The company has a market cap of 889.26 million GBP. The Firm provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. It has 22.46 P/E ratio. The Company’s divisions are Genus PIC, Genus ABS and Genus Asia.